When

Thursday, October 22, 2026

6:30 PM-8:30 PM ET

WheRE

Online - Virtual Live Stream

Online - Virtual Live Stream

send to phone
faculty
Monica Gandhi, MD, MPH
Director, University of California, San Francisco (UCSF)
Bay Area Center for AIDS Research (CFAR)
Professor of Medicine and Associate Chief
Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, “Ward 86” HIV Clinic, San Francisco General Hospital
San Francisco, California
Paul E. Sax, MD
Professor of Medicine
Harvard Medical School
Clinical Director, Division of Infectious Diseases
Brigham and Women’s Hospital
Boston, Massachusetts
Meredith E. Clement, MD, MHSc
Associate Professor
Department of Medicine - Infectious Diseases
University of Colorado Anschutz Medical Campus
Denver, Colorado

Click "Attend Event" to register for the livestream.

Prefer to participate in-person in Washington, DC? Register here:  ExchangeCME.com/HIVShowcaseDCLive

Program Description

Long-acting injectable (LAI) preexposure prophylaxis (PrEP) and antiretroviral therapy (ART) have transformed HIV prevention and care in the last several years, requiring clinicians to adjust decision-making practices and clinic protocols to provide and increase accessibility to these therapies.  In this Interactive Showcase CME symposium, learners will review the latest LAI PrEP or ART data, appropriate clinical application, and optimal LAI clinic protocols with Drs. Paul Sax, Monica Gandhi, and Meredith Clement. Take a walk through our narrated LAI PrEP and ART poster gallery; hear faculty discuss nuances of LAI PrEP and ART use in clinical practice; and make decisions in a clinical case series. Learners will leave with a greater understanding of patient selection, approaches to unique clinical scenarios, and options to improve workflow protocols around LAI PrEP and ART.

Target Audience

The educational design of this activity addresses the needs of infectious disease and HIV medicine MDs, NPs, PAs, along with nurses and pharmacists involved in the treatment of patients with HIV.

Educational Objectives

Upon completion of this activity, participants will be better prepared to:

  1. Review efficacy, safety, and patient preference data supporting LAI PrEP and ART as options to improve adherence
  2. Apply evidence-informed decision-making strategies to optimize selection, initiation, and monitoring of LAI PrEP and ART
  3. Implement and refine advanced clinical workflows to expand equitable access to LAI PrEP and ART

Physician Accreditation Statement

Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Integritas designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Pharmacy Credit Designation

Global Education Group designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-26-025-L02-P)

This is a knowledge-based activity.

Contact Information

For information about the accreditation (ACCME credit) of this program, please contact Integritas at info@exchangecme.com
For information about the accreditation (ACPE credit) of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must complete the pretest, pass the posttest with a 70% score or higher, and submit an evaluation form. Pharmacists must check CPE monitor for their credit within 60 days of activity completion. Credit cannot be claimed after 60 days. 

Fee Information

There is no fee for this educational activity.

Disclosures of Relevant Financial Relationships

Integritas Communications and Global adhere to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.  
 
All relevant financial relationships have been mitigated. 
The planners and managers at Integritas Communications and Global have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integritas Communications and Global do not recommend the use of any agent outside of the labeled indications.  
 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

 

Register Now

attend event

This activity is provided by Integritas Communications. (ACCME Credit)
This activity is jointly provided by Global Education Group (Global) and Integritas Communications. (ACPE Credit)
 
This activity is supported by an educational grant from ViiV Healthcare.
 
Related events
OCT
20
2026
Mechanism to Medicine™
1.50 CME

Drilling Down on Interleukin-33:

New Treatment Avenues for COPD and Acute Respiratory Infections

Time: 5:30 AM-7:30 AM PT
Venue: Sheraton Phoenix Downtown (Phoenix Ballroom C)
Location: Phoenix, AZ
Faculty: Professor Tom Wilkinson, MA Cantab, MBBS, PhD, FRCP, FERS; Professor James Dodd, MBCHB, MRCP, PhD
Register Now
OCT
22
2026
An Interactive Showcase™
1.50 CME/CE

LIVE: Optimizing Outcomes with LAI PrEP and ART

Advanced Clinical Decision Making in HIV Care

Time: 6:30 PM-8:30 PM ET
Venue: ID Week - Marriott Marquis Salon 6
Location: Washington, DC
Faculty: Monica Gandhi, MD, MPH; Paul E. Sax, MD; Meredith E. Clement, MD, MHSc
Register Now